True Private Wealth Advisors Biond Vax Pharmaceuticals Ltd. Transaction History

True Private Wealth Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.96 - $1.26 $8,160 - $10,710	-8,500 Reduced 15.32%	47,000 $34,000
Q2 2022 Jul 28, 2022	BUY	$1.16 - $1.88 $6,959 - $11,280	6,000 Added 12.12%	55,500 $64,000
Q1 2022 May 09, 2022	BUY	$1.15 - $2.34 $4,024 - $8,189	3,500 Added 7.61%	49,500 $79,000
Q4 2021 Feb 11, 2022	BUY	$1.48 - $2.92 $28,120 - $55,480	19,000 Added 70.37%	46,000 $108,000
Q3 2021 Nov 05, 2021	BUY	$2.15 - $3.44 $25,800 - $41,280	12,000 Added 80.0%	27,000 $59,000
Q2 2021 Aug 10, 2021	BUY	$2.6 - $3.91 $7,800 - $11,730	3,000 Added 25.0%	15,000 $43,000
Q1 2021 May 12, 2021	BUY	$3.1 - $5.95 $37,200 - $71,400	12,000 New	12,000 $46,000

Ticker BVXV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 18,678,800
Market Cap $12M
Description
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Götting...

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on True Private Wealth Advisors with notifications on news.